Mechanism, and treatment of anti-CV2/CRMP5 autoimmune pain is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2024). On theSindex it has a DataRank of 0. It has been cited 7 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 3R01NS120663-01A1S2
CRMP2 Phosphorylation: A Novel Target for Alzheimer's Disease?
National Institutes of Health
Grant: 5R01NS119263-04
Anti-CV2 autoantibodies unmask a CRMP5/GluN2B pain signaling hub
National Institutes of Health
Grant: 5R01NS098772-03
CRMP2, mitochondria, and Huntington’s disease
French National Research Agency (ANR)
Grant: ANR-18-RHUS-0012
French National Research Agency (ANR)
Grant: ANR-11-LABX-0042
National Institutes of Health
Grant: 1R01NS042852-01A1
N-Methyl and Other Peptide Inhibitors of Fibrillogenesis
NIDA NIH HHS
Grant: R01 DA042852
NINDS NIH HHS
Grant: R01 NS098772
NINDS NIH HHS
Grant: R01 NS119263
NINDS NIH HHS
Grant: R01 NS120663
Fields of Study
Keywords
Sustainable Development Goals